Болотов Валерий Дмитриевич (RU),Бродский Илья Борисович (RU),Вайншток Игорь Измаилович (RU),Мацулевич Тамара Васильевна (RU)
申请号：
RU2013129942/15
公开号：
RU2013129942A
申请日:
2013.07.01
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
1. Biopharmaceutical composition in powder form, normalizing dyslipidemic disorders comprising cells of probiotic bifidobacteria and / or lactobacilli, sorbent food or pharmaceutical grade quality and polysaccharide components, wherein the resulting cells of probiotic bacteria sorption conglomerate form the sorbent, and simultaneously the polysaccharide component auxiliary and prebiotikom.2. A composition according to claim 1, characterized in that the powder is enclosed in capsules or in sachets dispensed sashe.3 type. A composition according to claim 2, characterized in that the powder is intended for use in liquid vide.4. A composition according to any one of claims 1-3, wherein the medicament is a sredstvo.5. A composition according to any one of claims 1-3, characterized in that it is a biologically active additive to food (food supplement, dietary supplement) .6. A composition according to claim 1, characterized in that the probiotic bacteria are selected from: Bifidobacterium longum, Bifidobacterium bifidum, Bifidobacterium adolescentis, Lactobacillus casei, Lactobacillus breve, Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus fermentum or kombinatsii.7. A composition according to claim 1, characterized in that the sorbent food or pharmaceutical grade quality is selected from the group: lignin hydrolysis or medical, activated carbon, microcrystalline cellulose, colloidal silica or their kombinatsii.8. The composition of claim 1 wherein the polysaccharide component is selected from the group of plant polysaccharides: gum arabic, inulin or smes.9. A composition according to claim 1, characterized in that it contains probiotic bacteria in an amount 10-10KOE / g poroshka.10. A composition according to claim 1 or 2, characterized in that the average size h1. Биофармацевтическая композиция в виде порошка, нормализующая дислипидемические нарушения, содержащая клетки пробиотических бифидо- и/или лактобактерий, сорбент пищевой или фармацевтической кат
